Epic Research

Wednesday, December 19, 2012

Epic Update : NATCO Pharma

NATCO Pharma has received approval from the US Food & Drug Administration (USFDA), of its Abbreviated New Drug Application (ANDA) for Lansoprazole Delayed Release Capsules, USP, 15 mg and 30 mg for the prescription market. The shipments of this product will commence immediately.

Get Free Penny Stock Tips,MCX Tips,Stock Tips,Forex TipsNCDEX Tips,Commodity Tips,Share Tips,commodity tips free trial, nifty free tips,commodity trading tips, shares tips, ShareMarket Tips, Stock Market Tips, free stock tips on mobileStock trading tips,Intraday Tips.

No comments:

Post a Comment